Greater Glasgow and Clyde Medicines

Medicines Update -2021

For all prescribers and health professionals both in primary care and the acute sector.

Please note, Medicines Update blogs are correct at the time of publication.

All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site.  Click here for an index to all previous editions.  If you would like a copy of a previous edition, please contact  medicines.update@ggc.scot.nhs.uk

Click here for further information on Medicines Update and recent survey results.

If you would like to contribute to Medicines Update, click here for a guide to blog writing.

Management of Type 2 Diabetes – What’s New?

Posted: Friday, February 26, 2021

Category - Medicines Update

Management of Type 2 Diabetes – What’s New?

Summary

  • Sodium-glucose co-transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists benefits in cardiovascular and renal outcomes
  • Canagliflozin and Diabetic Kidney disease (DKD) licence extension
  • Semaglutide, the first oral GLP-1 receptor agonist
Read More...

Guidance At End Of Life (GAEL) - Updated

Posted: Friday, February 26, 2021

Category - Medicines Update

The updated guidance includes:

Read More...

Apremilast - New prescribing and supply arrangements

Posted: Friday, February 26, 2021

Category - Medicines Update

From February 2021, the maintenance dose of apremilast (one 30mg tablet twice daily) will be prescribed by the patient’s GP (one pack of 56 tablets per prescription). Specialist dermatology and rheumatology services will continue to prescribe the initial titration pack for new patients, and as before this will be dispensed in community pharmacies.

Read More...

Pico 7® dressing kit for use in post-op caesarean section incisional sites

Posted: Tuesday, February 23, 2021

Category - Medicines Update

Key messages

  • Pico 7® Single Use Negative Pressure Wound Therapy (sNPWT) dressing kit will be initiated on wound closure in theatre and will remain in situ for one week, under the ongoing care of acute midwives
  • When used for this indication, Pico 7® sNPWT kit or additional Pico 7® dressings should not be prescribed in Primary Care
  • Women will be provided with details of acute midwife and who to contact if a new dressing is required or for further advice on device
Read More...